蛋白质MRI对比剂作为精密分子成像的有效方法
Dongjun Li1, Michael Kirberger, Jingjuan Qiao
1From the Center for Diagnostics and Therapeutics, Advanced Translational Imaging Facility, Department of Chemistry, Georgia State University, Atlanta, GA (D.L., M.K., J.Q., Z.G., S.X., P.F., J.J., S.T., M.S., O.I., K.H., J.J.Y.); and InLighta BioSciences, LLC, Marietta, GA (Y.X., J.J.Y).
Investigative radiology
|January 5, 2024
概括
研究人员开发了先进的向蛋白质的MRI对比剂 (ProCA),可显著增强早期疾病检测的成像效果. 这些新型药物提供了更好的放松性和生物标志物向性,为癌症和其他慢性疾病的精确诊断铺平了道路.
科学领域:
- 生物医学成像技术 生物医学成像技术
- 分子成像分子成像技术
- 对比剂开发对比剂开发
背景情况:
- 磁共振成像 (MRI) 对于疾病表征至关重要,但在精确的分子成像方面面临挑战.
- 目前的对比剂在量化生物标志物检测中难以平衡金属结合亲和性和放松性.
- 克服这些局限性是早期疾病检测,分期和治疗监测的关键.
研究的目的:
- 引入理想精度分子成像对比剂的标准.
- 报告开发向蛋白质的MRI对比剂 (ProCA) 的进展.
- 为了证明ProCA在高分辨率,定量分子成像方面的潜力.
主要方法:
- 设计和优化了一种针对蛋白质的新型MRI对比剂 (ProCA).
- 专注于通过二次领域和相关时间贡献来增强放松性.
- 为高放松性,金属稳定性和特定生物标志物准而设计的ProCA.
主要成果:
- 达到双重高的r1和r2放松度值 (比1.5T的临床药物高6-10倍).
- 在高磁场下表现出显著更高的放松性,以提高分辨率.
- 开发出具有强烈生物标志物亲和力和特异性的ProCA32药物,增强稳定性和抗转移性.
结论:
- 针对蛋白质的MRI对比剂 (ProCA) 为精确的分子成像提供了卓越的性能.
- 在体内,ProCA32.collagen使肝转移和纤维化的早期检测成为可能.
- 这些ProCA具有重要的翻译潜力,用于临床前和临床精确诊断和治疗.
相关概念视频
Magnetic Resonance Imaging
5.2K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.2K
Applications Of NMR In Biology
3.7K
Nuclear magnetic resonance (NMR) spectroscopy is a very valuable analytical technique for researchers. It has been used for more than 50 years as an analytical tool. F. Bloch and E. Purcell formulated NMR in 1946 and won the 1952 Nobel Prize in Physics for their work. Biological macromolecules such as proteins, nucleic acids, lipids, and organic molecules including pharmaceutical compounds, can be studied using this versatile tool that exploits the magnetic properties of certain nuclei.
3.7K
Proteomics
7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)
326
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT) is an advanced Nuclear Magnetic Resonance (NMR) technique specifically designed to detect and enhance the signals of low-abundance nuclei, such as carbon-13 and nitrogen-15, in small molecules. The fundamental principle behind INEPT is the transfer of polarization from a more abundant and highly polarizable nucleus, typically hydrogen-1, to the low-abundance nucleus of interest. This process effectively boosts the NMR signal of the...
326
Positron Emission Tomography
4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K


